Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Medicare fraud costs Americans about $60 billion each year and healthcare plans are stepping in spread awareness and stop ...

Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with ...

A total of 17 lots are now part of the recall of Clonazepam because some cartons have the wrong strength on the label.

Patients with pulmonary arterial hypertension often experienced delays in obtaining a correct diagnosis. The American Lung ...

A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...

The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Roche’s Evrysdi (risdiplam) is the market leader among the drugs for spinal muscular atrophy (SMA). Biogen’s Spinraza ...

Laser therapies may help with pain after a root canal, but a review of published studies shows their effectiveness can vary significantly. Further research is needed to identify the optimal approach.

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...